vs
Side-by-side financial comparison of BGSF, INC. (BGSF) and Pulmonx Corp (LUNG). Click either name above to swap in a different company.
BGSF, INC. is the larger business by last-quarter revenue ($22.0M vs $20.6M, roughly 1.1× Pulmonx Corp). BGSF, INC. runs the higher net margin — -5.3% vs -66.3%, a 61.1% gap on every dollar of revenue. On growth, Pulmonx Corp posted the faster year-over-year revenue change (-8.7% vs -9.4%). Over the past eight quarters, Pulmonx Corp's revenue compounded faster (-0.5% CAGR vs -5.3%).
BGSF Inc. is a leading U.S.-headquartered workforce solutions firm that provides tailored staffing, talent recruitment, and end-to-end workforce management services. It serves core segments including information technology, healthcare, professional administration, light industrial, and creative industries, catering to small, mid-sized and large enterprise clients across North America.
Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.
BGSF vs LUNG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $22.0M | $20.6M |
| Net Profit | $-1.2M | $-13.7M |
| Gross Margin | 35.0% | 77.9% |
| Operating Margin | -17.6% | -40.9% |
| Net Margin | -5.3% | -66.3% |
| Revenue YoY | -9.4% | -8.7% |
| Net Profit YoY | -18.2% | 5.5% |
| EPS (diluted) | $-0.12 | $-0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $20.6M | ||
| Q4 25 | $22.0M | $22.6M | ||
| Q3 25 | $26.9M | $21.5M | ||
| Q2 25 | $23.5M | $23.9M | ||
| Q1 25 | $20.9M | $22.5M | ||
| Q4 24 | $24.3M | $23.8M | ||
| Q3 24 | $29.8M | $20.4M | ||
| Q2 24 | $25.7M | $20.8M |
| Q1 26 | — | $-13.7M | ||
| Q4 25 | $-1.2M | $-10.4M | ||
| Q3 25 | $-5.8M | $-14.0M | ||
| Q2 25 | $-3.7M | $-15.2M | ||
| Q1 25 | $-722.0K | $-14.4M | ||
| Q4 24 | $-981.0K | $-13.2M | ||
| Q3 24 | $-804.0K | $-14.1M | ||
| Q2 24 | $-761.0K | $-15.3M |
| Q1 26 | — | 77.9% | ||
| Q4 25 | 35.0% | 77.6% | ||
| Q3 25 | 35.9% | 74.7% | ||
| Q2 25 | 35.8% | 72.1% | ||
| Q1 25 | 36.2% | 72.5% | ||
| Q4 24 | 35.9% | 74.0% | ||
| Q3 24 | 35.9% | 73.7% | ||
| Q2 24 | 37.3% | 73.7% |
| Q1 26 | — | -40.9% | ||
| Q4 25 | -17.6% | -43.8% | ||
| Q3 25 | -3.5% | -66.9% | ||
| Q2 25 | -18.8% | -62.0% | ||
| Q1 25 | 1.6% | -64.6% | ||
| Q4 24 | -15.7% | -56.5% | ||
| Q3 24 | -3.4% | -69.3% | ||
| Q2 24 | -5.7% | -75.2% |
| Q1 26 | — | -66.3% | ||
| Q4 25 | -5.3% | -46.1% | ||
| Q3 25 | -21.6% | -64.9% | ||
| Q2 25 | -15.9% | -63.6% | ||
| Q1 25 | -3.5% | -64.1% | ||
| Q4 24 | -4.0% | -55.4% | ||
| Q3 24 | -2.7% | -69.4% | ||
| Q2 24 | -3.0% | -73.7% |
| Q1 26 | — | $-0.33 | ||
| Q4 25 | $-0.12 | $-0.25 | ||
| Q3 25 | $-0.52 | $-0.34 | ||
| Q2 25 | $-0.34 | $-0.38 | ||
| Q1 25 | $-0.06 | $-0.36 | ||
| Q4 24 | — | $-0.33 | ||
| Q3 24 | $-0.07 | $-0.36 | ||
| Q2 24 | $-0.07 | $-0.39 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $61.6M |
| Total DebtLower is stronger | — | $37.3M |
| Stockholders' EquityBook value | $48.1M | $45.8M |
| Total Assets | $57.8M | $120.0M |
| Debt / EquityLower = less leverage | — | 0.82× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $61.6M | ||
| Q4 25 | — | $69.8M | ||
| Q3 25 | $41.2M | $76.5M | ||
| Q2 25 | $2.8M | $75.5M | ||
| Q1 25 | $2.0M | $74.6M | ||
| Q4 24 | $32.0K | $70.9M | ||
| Q3 24 | $262 | $63.3M | ||
| Q2 24 | $226 | $63.5M |
| Q1 26 | — | $37.3M | ||
| Q4 25 | — | $37.1M | ||
| Q3 25 | — | $37.1M | ||
| Q2 25 | — | $37.1M | ||
| Q1 25 | — | $37.2M | ||
| Q4 24 | — | $37.2M | ||
| Q3 24 | — | $37.2M | ||
| Q2 24 | — | $37.2M |
| Q1 26 | — | $45.8M | ||
| Q4 25 | $48.1M | $54.1M | ||
| Q3 25 | $50.7M | $60.0M | ||
| Q2 25 | $78.3M | $69.1M | ||
| Q1 25 | $81.8M | $77.7M | ||
| Q4 24 | $82.3M | $85.8M | ||
| Q3 24 | $82.9M | $93.9M | ||
| Q2 24 | $83.2M | $101.2M |
| Q1 26 | — | $120.0M | ||
| Q4 25 | $57.8M | $129.3M | ||
| Q3 25 | $83.6M | $138.3M | ||
| Q2 25 | $149.7M | $147.2M | ||
| Q1 25 | $152.3M | $150.7M | ||
| Q4 24 | $150.1M | $162.8M | ||
| Q3 24 | $157.3K | $167.4M | ||
| Q2 24 | $159.8K | $172.6M |
| Q1 26 | — | 0.82× | ||
| Q4 25 | — | 0.69× | ||
| Q3 25 | — | 0.62× | ||
| Q2 25 | — | 0.54× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.40× | ||
| Q2 24 | — | 0.37× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.7M | — |
| Free Cash FlowOCF − Capex | $1.7M | — |
| FCF MarginFCF / Revenue | 7.6% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.0K | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $1.7M | $-7.1M | ||
| Q3 25 | $-4.8M | $-8.2M | ||
| Q2 25 | $2.2M | $-3.9M | ||
| Q1 25 | $1.1M | $-13.2M | ||
| Q4 24 | $3.2M | $-6.7M | ||
| Q3 24 | $6.5M | $-7.2M | ||
| Q2 24 | $7.3M | $-5.8M |
| Q1 26 | — | — | ||
| Q4 25 | $1.7M | $-7.1M | ||
| Q3 25 | $-4.9M | $-8.3M | ||
| Q2 25 | $2.1M | $-4.0M | ||
| Q1 25 | $1.0M | $-13.5M | ||
| Q4 24 | $2.5M | $-6.8M | ||
| Q3 24 | $6.5M | $-7.7M | ||
| Q2 24 | $7.3M | $-6.2M |
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | -31.4% | ||
| Q3 25 | -18.1% | -38.4% | ||
| Q2 25 | 9.1% | -16.6% | ||
| Q1 25 | 5.0% | -60.0% | ||
| Q4 24 | 10.2% | -28.8% | ||
| Q3 24 | 21.7% | -37.6% | ||
| Q2 24 | 28.5% | -30.0% |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 0.1% | ||
| Q3 25 | 0.4% | 0.4% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.1% | 1.3% | ||
| Q4 24 | 3.0% | 0.5% | ||
| Q3 24 | 0.0% | 2.0% | ||
| Q2 24 | 0.0% | 2.3% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BGSF
| Contract Field Talent | $21.4M | 97% |
| Other | $595.0K | 3% |
LUNG
Segment breakdown not available.
